Pliant Therapeutics PLRX
NASDAQ PLRX
$1.08 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Pliant Therapeutics (PLRX) Preferred Stock Liabilities (2019 - 2020)

Updated

Pliant Therapeutics (PLRX) recorded Preferred Stock Liabilities of $238.31 million in Q1 2020, up 27.9% from the prior quarter.

Analysis

Pliant Therapeutics (PLRX) Preferred Stock Liabilities (2019 - 2020) Analysis & Trends

At the end of FY2019, Pliant Therapeutics reported Preferred Stock Liabilities of $186.28 million.

  • Per Business Quant, the preceding three quarters came in at $186.28 million (Q4 2019), $136.18 million (Q3 2019) and $134.81 million (Q2 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Pliant Therapeutics 66.87 Mn 66.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 238.31 Mn
Dec 31, 2019 186.28 Mn
Sep 30, 2019 136.18 Mn
Jun 30, 2019 134.81 Mn
API Access

Pliant Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=PLRX&period=max&api_key=YOUR_API_KEY